Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 08 April 2013 | By Louise Zornoza,
Brazil's National Health Surveillance Agency, Anvisa, has released a pharmaceutical production cleaning validation guide which, according to the agency, is based on international guidelines.
The document is directed at pharmaceutical manufacturers in Brazil and is intended to be a simple, practical and structured approach for executing the cleaning validation necessary to demonstrate that a company's manufacturing procedures are effective in removing contaminants or lowering them to acceptable levels.
The production of pharmaceuticals involves complex chemical processes that can lead to the production of a myriad of byproducts, including toxins. The cleaning validation process is one of the most effective ways to control contamination in the active pharmaceutical ingredients.
The validation is a regulatory requirement in Brazil stemming from resolutions RDC No. 17/2010 and RDC nº 249/2005.
Tags: brazil